Physician profile
Daniel P Taylor
NPI 1043270812
$929.43
in general payments reported to CMS, 2019-2025
14 companies · $94.22 in 2025
The $94.22 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $77.14 · 2021: $40.24 · 2022: $82.92 · 2023: $316 · 2024: $203 · 2025: $94.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $515 · Education: $97.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $515.09 |
| Education | $97.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $201.44 | 2022-2025 | Tyrvaya, Ryzumvi |
| Mallinckrodt Hospital Products INC. | $156.06 | 2022-2023 | Acthar |
| Allergan, INC. | $108.92 | 2019-2021 | |
| Alcon Vision LLC | $94.87 | 2019-2023 | Total30 |
| Sun Pharmaceutical Industries INC. | $82.25 | 2020-2023 | Cequa |
| Bausch & Lomb Americas INC. | $48.04 | 2023-2025 | Infuse, Xiidra |
| Coopervision INC. | $46.34 | 2023-2025 | Clariti Contact Lens, Myday Contact Lens, Misight Contact Lens |
| Sight Sciences, INC. | $46.13 | 2024 | Omni Surgical System |
| Abbvie INC. | $35.66 | 2022-2023 | Alphagan P, Lumigan, Vuity |
| Novartis Pharmaceuticals Corporation | $32.75 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $28.56 | 2025 | Xdemvy |
| Tearlab Corp | $18.66 | 2024 | Scoutpro Osmolarity System |
| Biotissue Holdings INC. | $16.93 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $12.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.